Milestone Pharmaceuticals, Inc. (MIST)
0.6482
-0.05
(-7.76%)
USD |
NASDAQ |
Oct 23, 16:00
0.65
0.00 (0.00%)
After-Hours: 20:00
Milestone Pharmaceuticals Market Cap : 80.70M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 80.70M |
| October 22, 2026 | 87.48M |
| October 21, 2026 | 86.56M |
| October 20, 2026 | 89.45M |
| October 19, 2026 | 87.16M |
| October 16, 2026 | 88.06M |
| October 15, 2026 | 98.91M |
| October 14, 2026 | 98.09M |
| October 13, 2026 | 95.34M |
| October 12, 2026 | 100.28M |
| October 09, 2026 | 95.24M |
| October 08, 2026 | 88.66M |
| October 07, 2026 | 94.27M |
| October 06, 2026 | 95.14M |
| October 05, 2026 | 97.03M |
| October 02, 2026 | 100.81M |
| October 01, 2026 | 101.55M |
| September 30, 2026 | 107.78M |
| September 29, 2026 | 102.09M |
| September 28, 2026 | 99.03M |
| September 25, 2026 | 98.15M |
| September 24, 2026 | 98.96M |
| September 23, 2026 | 107.32M |
| September 22, 2026 | 114.66M |
| September 21, 2026 | 114.26M |
| Date | Value |
|---|---|
| September 18, 2026 | 114.02M |
| September 17, 2026 | 114.49M |
| September 16, 2026 | 110.70M |
| September 15, 2026 | 115.50M |
| September 14, 2026 | 118.20M |
| September 11, 2026 | 122.02M |
| September 10, 2026 | 130.72M |
| September 09, 2026 | 133.21M |
| September 08, 2026 | 140.06M |
| September 04, 2026 | 149.40M |
| September 03, 2026 | 150.64M |
| September 02, 2026 | 146.91M |
| September 01, 2026 | 141.93M |
| August 31, 2026 | 144.42M |
| August 28, 2026 | 144.42M |
| August 27, 2026 | 148.15M |
| August 26, 2026 | 146.91M |
| August 25, 2026 | 144.42M |
| August 24, 2026 | 129.48M |
| August 21, 2026 | 131.35M |
| August 20, 2026 | 128.23M |
| August 19, 2026 | 134.46M |
| August 18, 2026 | 133.21M |
| August 17, 2026 | 136.95M |
| August 14, 2026 | 136.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 7.689M |
| NervGen Pharma Corp. | 152.17M |
| Appili Therapeutics, Inc. | 0.9001M |
| Clearmind Medicine, Inc. | 12.59M |
| Lexaria Bioscience Corp. | 5.090M |
Market Cap Related Metrics
| PS Ratio | 32.62 |
| Price to Book Value | 4.430 |
| Price | 0.6482 |
| Earnings Yield | -107.0% |